Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study

We conducted a randomized trial to evaluate whether melphalan-prednisone (MPH-P) treatment administered just after diagnosis improves survival of stage I multiple myeloma (MM). Between January 1987 and March 1993, 145 consecutive previously untreated patients with stage I MM were randomized between...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardi, A, Mora, O, Tinelli, C, Valentini, D, Brugnatelli, S, Spanedda, R, De Paoli, A, Barbarano, L, Di Stasi, M, Giordano, M, Delfini, C, Nicoletti, G, Bergonzi, C, Rinaldi, E, Piccinini, L, Ascari, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374495/
https://www.ncbi.nlm.nih.gov/pubmed/10755397
http://dx.doi.org/10.1054/bjoc.1999.1087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374495/
https://www.ncbi.nlm.nih.gov/pubmed/10755397
http://dx.doi.org/10.1054/bjoc.1999.1087

Ejemplares similares